ALPHA-ORBIT - A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Navenibart in Adolescent and Adult Participants with Type 1 and Type 2 Hereditary Angioedema (HAE)

• DOI: 10.1016/j.jaci.2024.12.622
• Publication Date: 2025-02-10T10:07:09Z
• Authors: Markus Magerl; William Lumry; Timothy Craig; Andrea Zanichelli; Emel Aygören Pursun; John Anderson; Stephen Betschel; Raffi Tachdjian; Aleena Banerji; Claire Van Eenwyk; Harold Wright; Theodora Cohen; Christopher Morabito; Michihiro Hide; Marc Riedl